Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial
Articolo
Data di Pubblicazione:
2019
Abstract:
Previous trials suggest that vasopressin may improve outcomes in patients with vasodilatory shock. The aim of this study was to evaluate whether vasopressin could be superior to norepinephrine to improve outcomes in cancer patients with septic shock.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Hajjar, Ludhmila Abrahão; Zambolim, Cristiane; Belletti, Alessandro; de Almeida, Juliano Pinheiro; Gordon, Anthony C; Oliveira, Gisele; Park, Clarice Hyesuk Lee; Fukushima, Julia Tizue; Rizk, Stephanie Itala; Szeles, Tais Felix; Dos Santos Neto, Nestor Cordeiro; Filho, Roberto Kalil; Galas, Filomena Regina Barbosa Gomes; Landoni, Giovanni
Link alla scheda completa:
Pubblicato in: